You are here

  • Home
  • Archive
  • Volume 10, Issue 9
  • Phase I/II clinical trial of a helper peptide vaccine plus PD-1 blockade in PD-1 antibody-naïve and PD-1 antibody-experienced patients with melanoma (MEL64)

Citation Tools

Article menu

This article has a correction. Please see:

Clinical/translational cancer immunotherapy
Original research
Phase I/II clinical trial of a helper peptide vaccine plus PD-1 blockade in PD-1 antibody-naïve and PD-1 antibody-experienced patients with melanoma (MEL64)

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Vavolizza RD, Petroni GR, Mauldin IS, et al
Phase I/II clinical trial of a helper peptide vaccine plus PD-1 blockade in PD-1 antibody-naïve and PD-1 antibody-experienced patients with melanoma (MEL64)
Journal for ImmunoTherapy of Cancer 2022;10:e005424. doi: 10.1136/jitc-2022-005424